Pasithea Therapeutics Corp. (KTTAW)
KTTAW Stock Price Chart
Explore Pasithea Therapeutics Corp. interactive price chart. Choose custom timeframes to analyze KTTAW price movements and trends.
KTTAW Company Profile
Discover essential business fundamentals and corporate details for Pasithea Therapeutics Corp. (KTTAW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Sept 2021
Employees
4.00
Website
http://pasitheaclinics.comCEO
Tiago Reis Marques
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
KTTAW Financial Timeline
Browse a chronological timeline of Pasithea Therapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$0.66 .
Earnings released on 15 May 2025
EPS came in at -$1.61 .
Earnings released on 30 Sept 2023
EPS came in at -$0.00 .
Earnings released on 30 Jun 2023
EPS came in at -$0.14 .
Earnings released on 31 Mar 2023
EPS came in at -$10.55 .
Earnings released on 31 Dec 2022
EPS came in at -$0.15 , while revenue for the quarter reached $240.71K .
KTTAW Stock Performance
Access detailed KTTAW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.